Diabetic nephropathy — kidney damage from diabetes — usually develops silently. The earliest sign is not a symptom but a laboratory finding: small amounts of albumin protein leaking into the urine. By the time visible symptoms such as foamy urine, ankle swelling, and fatigue appear, the kidneys have lost significant function. That is why annual urine and blood screening is the centerpiece of early detection, and why several newer therapies can now slow progression dramatically.
Why Nephropathy Is Silent at First
The kidneys have substantial reserve. Each kidney contains roughly one million filtering units called nephrons, and the body can function with far fewer. Diabetes damages nephrons gradually through several mechanisms: high glucose stiffens the small blood vessels in the kidney, increases pressure inside the glomerular filters, and triggers inflammation and fibrosis. People typically lose function for years before they notice any symptom. This means symptoms alone are not a reliable warning — annual screening is essential.
Stages of Diabetic Kidney Disease
| Stage | eGFR (mL/min/1.73 m²) | Description | Typical Symptoms |
|---|---|---|---|
| G1 | ≥ 90 | Normal or high; kidney damage present (e.g., albuminuria) | None |
| G2 | 60–89 | Mildly decreased | None to mild |
| G3a | 45–59 | Mild to moderate decrease | Possible fatigue, mild edema |
| G3b | 30–44 | Moderate to severe decrease | Edema, hypertension, anemia onset |
| G4 | 15–29 | Severe decrease | Nausea, itching, poor appetite, fatigue |
| G5 | < 15 | Kidney failure | Severe uremic symptoms; dialysis or transplant needed |
Albuminuria is graded separately:
- A1: UACR under 30 mg/g (normal)
- A2: UACR 30 to 300 mg/g (moderately increased; formerly microalbuminuria)
- A3: UACR over 300 mg/g (severely increased; formerly macroalbuminuria)
Early Symptoms — When Anything Is Noticeable
Foamy or Bubbly Urine
When the kidneys leak protein into the urine, surface tension changes and bubbles form on the toilet water surface that linger after flushing. Most people occasionally see foamy urine after a strong stream — what matters is persistent foam present at every urination. This is one of the most specific early signals of proteinuria.
Swelling (Edema)
Loss of albumin in the urine lowers blood protein levels, allowing fluid to leak into tissues. Swelling is typically:
- Bilateral in the ankles, feet, and lower legs
- Worse late in the day, better after sleeping with legs elevated
- Pitting when pressed
- Sometimes around the eyes in the morning (periorbital edema)
High Blood Pressure
Worsening hypertension — especially if previously well-controlled — can be both a cause and a consequence of diabetic kidney disease. A sudden need for additional blood pressure medication is a warning to check kidney function.
Fatigue
Unexplained tiredness, especially in the afternoon, can reflect early anemia from reduced kidney production of erythropoietin, the hormone that stimulates red blood cell production.
Symptoms of Advanced Kidney Disease
- Nausea, vomiting, loss of appetite: waste products such as urea build up in the bloodstream (uremia)
- Metallic taste or “fishy” breath
- Severe itching (uremic pruritus): often worse on the back and arms
- Muscle cramps or twitching: from electrolyte imbalances
- Restless legs at night
- Shortness of breath: from fluid overload or anemia
- Confusion, difficulty concentrating, drowsiness
- Decreased urine output
- Easy bruising or bleeding
- Pale skin from anemia
These late symptoms indicate eGFR is often under 30 and warrant urgent specialist evaluation.
Screening — The Real Early-Warning System
Because nephropathy is so quiet, the American Diabetes Association recommends:
- Urine albumin-to-creatinine ratio (UACR) on a spot urine sample, annually, starting at type 2 diagnosis and 5 years after type 1 diagnosis
- Estimated glomerular filtration rate (eGFR) from serum creatinine, annually, at the same intervals
- More frequent monitoring (every 6 months) for people with established kidney disease
A single UACR over 30 mg/g is not enough — exercise, fever, hyperglycemia, and urinary tract infection can transiently raise albumin. The diagnosis requires two of three samples within 3 to 6 months.
Risk Factors That Speed Progression
- Poor glycemic control (high A1C)
- Uncontrolled blood pressure
- Smoking
- Family history of kidney disease
- Obesity
- High dietary sodium intake
- NSAID use
- Contrast dye exposure
- Concurrent cardiovascular disease
Treatment — What Modern Kidney Care Looks Like
SGLT2 Inhibitors
Empagliflozin, dapagliflozin, canagliflozin, and ertugliflozin are now considered first-line for diabetic kidney disease in adults with type 2 diabetes and eGFR generally above 20. Trials including EMPA-KIDNEY, DAPA-CKD, and CREDENCE showed reductions in kidney disease progression, cardiovascular events, and mortality. These medications work even in people without diabetes who have proteinuric kidney disease.
ACE Inhibitors and ARBs
Drugs like lisinopril, ramipril, losartan, and irbesartan reduce pressure inside the glomerulus and slow albuminuria. They are recommended for any person with diabetes and hypertension, and for normotensive people with albuminuria.
Finerenone
A nonsteroidal mineralocorticoid receptor antagonist approved for diabetic kidney disease. The FIDELIO-DKD and FIGARO-DKD trials showed it slows kidney function decline and cardiovascular events when added to maximum ACE/ARB therapy. Potassium levels must be monitored.
GLP-1 Receptor Agonists
Semaglutide, dulaglutide, and liraglutide also reduce albuminuria and may slow eGFR decline. The FLOW trial of semaglutide showed significant kidney and cardiovascular benefit.
Glycemic and Blood Pressure Control
- A1C targets are individualized — usually under 7 percent, sometimes higher in advanced disease where hypoglycemia risk rises
- Blood pressure target generally under 130/80 mmHg
- Sodium intake under 2,300 mg per day
- Statin therapy for most adults with diabetic kidney disease for cardiovascular protection
Dietary Considerations
- Moderate protein intake (about 0.8 g/kg/day for most adults with non-dialysis CKD)
- Reduce sodium
- Be cautious with potassium and phosphorus in advanced stages
- Work with a registered dietitian familiar with kidney disease
When to See a Nephrologist
- eGFR under 30 (always)
- UACR over 300 mg/g
- Rapid eGFR decline (more than 5 mL/min/year)
- Difficult-to-control hypertension
- Persistent hyperkalemia despite medication adjustment
- Unclear cause of kidney disease (rapid progression, very heavy proteinuria, hematuria)
For an overview of related conditions, see our resources on complications and prediabetes symptoms. The NIDDK overview of diabetic kidney disease and the KDIGO 2022 guidelines provide authoritative detail.
Prevention
- Annual UACR and eGFR screening
- Maintain A1C as close to individualized target as safely possible
- Control blood pressure with ACE/ARB-based regimens
- Avoid NSAIDs whenever possible
- Stop smoking
- Stay hydrated, especially around contrast imaging procedures
- Discuss SGLT2 inhibitor candidacy with your clinician — even people without significant kidney disease may benefit
- Treat urinary tract infections promptly
The Bottom Line
Diabetic nephropathy is almost always silent at first. By the time foamy urine, ankle swelling, rising blood pressure, or fatigue become noticeable, kidney damage is already in motion. Annual urine albumin and eGFR screening starting at diagnosis is the only reliable way to catch it early. Modern therapy — SGLT2 inhibitors, ACE inhibitors or ARBs, finerenone, and GLP-1 receptor agonists, layered onto glycemic and blood pressure control — can slow progression substantially and often delay or prevent dialysis. Late-stage symptoms (nausea, severe itching, decreased urine output) need urgent attention. Talk to your doctor about your latest UACR and eGFR — and which of the newer kidney-protective medications may be right for you.
